ferric citrate has been researched along with phosphorus in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Alférez, MJ; Barrionuevo, M; Campos, MS; Gómez-Ayala, AE; Hartiti, S; Lisbona, F; López-Aliaga, I; Moratalla, A; Pallarés, I | 1 |
| Hou, CC; Hsu, CH; Wu, TH; Yang, CS; Yang, WC; Young, EW | 1 |
| Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F | 1 |
| FINCH, CA; HEGSTED, DM; KINNEY, TD | 1 |
| Dwyer, J; Greene, T; Korbet, S; Koury, M; Lewis, J; Shapiro, W; Sika, M; Sinsakul, M; Smith, M | 1 |
| Anger, M; Blumenthal, SS; Chang, IJ; Dwyer, JP; Kaplan, M; Koury, MJ; Lewis, JB; Schulman, G; Sika, M; Smith, M; Zeig, S | 1 |
| Akiba, T; Chertow, GM; Fukagawa, M; Hirakata, H; Kumagai, Y; Nakayama, M; Sawada, K; Yokoyama, K | 1 |
| Chiang, SS; Lee, CT; Peng, YS; Shu, KH; Wu, IW; Wu, MJ; Wu, MS | 1 |
| Iida, A; Matsuo, A; Matsushita, M; Miyamoto, K; Tanimoto, M | 1 |
| Athreya, BP; Blumenthal, SS; Chang, IJ; Chuang, P; Dwyer, JP; Galphin, CM; Greene, T; Kant, KS; Koury, MJ; Lewis, JB; Linfert, DR; Manley, J; Nossuli, AK; Olivero, JJ; Schulman, G; Sika, M; Smith, MT; Whittier, FC; Zeig, S | 1 |
| Dwyer, JP; Niecestro, R; Rodby, R; Sinsakul, M; Umanath, K | 1 |
| Akagi, J; Cho, YM; Mizuta, Y; Ogawa, K; Toyoda, T | 1 |
| Dwyer, JP; Jackson, JH; Lewis, JB; Niecestro, R; Rodby, R; Sika, M; Umanath, K | 1 |
| Anraku, M; Fukagawa, M; Imafuku, T; Ishima, Y; Itoh, K; Kadowaki, D; Maeda, H; Maruyama, T; Matsushita, K; Miyamura, S; Okuda, T; Otagiri, M; Tanaka, M; Tominaga, Y; Watanabe, H; Yamasaki, K | 1 |
| Chillemi, S; Gerbeling, T; Hain, DJ; Huffman, JM; Koeper, DW; Loram, LC; Marinaro, M; Pergola, PE; Pritsiolas, JM; Rosenthal, MA | 1 |
| Iida, A; Matsushita, M; Ohta, T; Yamada, T | 1 |
| Chiu, YW; Lee, CC; Lee, CT; Leu, JG; Peng, YS; Tarng, DC; Wu, MJ; Wu, MS | 1 |
| Hashimoto, T; Ito, K; Matsumoto, Y; Nishino, N; Okuda, Y; Susai, H; Yamada, R; Yokoyama, K | 1 |
| Allen, MR; Avin, KG; Biruete, A; Chen, NX; Clinkenbeard, EL; Metzger, CE; Moe, SM; O'Neill, K; Srinivasan, S; Stacy, AJ; Swallow, EA; Vrabec, C | 1 |
2 review(s) available for ferric citrate and phosphorus
| Article | Year |
|---|---|
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors | 2005 |
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.
Topics: Anemia; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus | 2014 |
7 trial(s) available for ferric citrate and phosphorus
| Article | Year |
|---|---|
An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate.
Topics: Adult; Calcium Carbonate; Calcium Phosphates; Calcium, Dietary; Cross-Over Studies; Female; Ferric Compounds; Humans; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Dialysis | 2002 |
The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.
Topics: Adult; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Color; Constipation; Feces; Female; Ferric Compounds; Ferritins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Surveys and Questionnaires | 2012 |
Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Female; Ferric Compounds; Follow-Up Studies; Hematinics; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2013 |
Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.
Topics: Aged; Calcium; Dose-Response Relationship, Drug; Endpoint Determination; Female; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Hematinics; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis | 2014 |
Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Chelating Agents; Double-Blind Method; Female; Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Transferrin | 2015 |
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Israel; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Phosphorus; Renal Dialysis; Treatment Outcome; United States | 2015 |
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.
Topics: Adult; Chelating Agents; Cost Savings; Ferric Compounds; Hospital Costs; Hospitalization; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2015 |
10 other study(ies) available for ferric citrate and phosphorus
| Article | Year |
|---|---|
Effects of iron replenishment on iron, calcium, phosphorus and magnesium metabolism in iron-deficient rats.
Topics: Analysis of Variance; Anemia, Iron-Deficiency; Animal Feed; Animals; Ascorbic Acid; Body Weight; Calcium; Eating; Ferric Compounds; Ferrous Compounds; Food, Fortified; Hemoglobins; Iron; Iron Deficiencies; Magnesium; Male; Phosphorus; Random Allocation; Rats; Rats, Wistar; Tissue Distribution | 1996 |
The influence of diet on iron absorption; the interrelation of iron and phosphorus.
Topics: Animals; Body Weight; Diet; Ferric Compounds; Iron; Liver; Organophosphorus Compounds; Phosphorus; Phosphorus Compounds; Rats | 1949 |
The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
Topics: Animals; Calcium Carbonate; Ferric Compounds; Intestinal Absorption; Lanthanum; Male; Phosphorus; Rats; Rats, Sprague-Dawley | 2014 |
A 13-week subchronic toxicity study of ferric citrate in F344 rats.
Topics: Animals; Body Weight; Colitis; Eating; Eosinophilia; Female; Ferric Compounds; Food Additives; Lymph Nodes; Male; Phosphorus; Rats; Rats, Inbred F344; Spleen; Toxicity Tests, Subchronic | 2014 |
Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Ferric Compounds; Ferritins; Humans; Male; Middle Aged; Oxidative Stress; Phosphates; Phosphorus; Renal Dialysis | 2016 |
Ferric citrate controls serum phosphorus in dialysis patients: retrospective data
.
Topics: Adult; Aged; Aged, 80 and over; Chelating Agents; Female; Ferric Compounds; Ferritins; Humans; Male; Middle Aged; Phosphorus; Renal Dialysis; Retrospective Studies | 2017 |
Conventional and novel impacts of ferric citrate on iron deficiency anemia and phosphorus metabolism in rats.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Iron Deficiencies; Male; Phosphorus; Rats, Sprague-Dawley | 2020 |
Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Humans; Iron; Phosphates; Phosphorus; Renal Dialysis | 2022 |
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.
Topics: Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Iron; Phosphorus; Product Surveillance, Postmarketing; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factors; Homeostasis; Iron; Male; Minerals; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic; Transferrins | 2022 |